Evaluation of Lifetime participation in Intensive Top-level sports and Exercise

Recruiting

• Conditions: cardiomyopathy; heart muscle disease; 10082206; 10007510

• Registration Number: NL-OMON55187
• Lead Sponsor: Academisch Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 11 June 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 3000

Inclusion Criteria

>16 years old
Registered as elite athletes according to NOC*NSF (A-status, HP-status or
selection status)
Participation in the SMART screening

Exclusion Criteria

Unable to give inform consent

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The main objective of ELITE is to establish comprehensive cardiac baseline<br /><br>assessment in elite athletes consisting of electrocardiologic characteristics,<br /><br>VO2 max, peak load (in METS or Watt), cardiac biomarkers, lipid profile,<br /><br>ejection fraction (EF), wall thickness of the left and right ventricle, volume<br /><br>of left- and right atria and ventricles, myocardial tissue characteristics<br /><br>including fibrosis using late gadolinium enhancement (LGE), strain of left- and<br /><br>right ventricle, quantification of body composition, and cardiogenetics. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>na</p><br>